FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3008223946> ?p ?o ?g. }

• W3008223946 endingPage "502" @default.
• W3008223946 startingPage "493" @default.
• W3008223946 abstract "Objective To compare the efficacy of fingolimod and natalizumab in preventing regional grey matter (GM) and white matter (WM) atrophy in relapsing-remitting multiple sclerosis (RRMS) over 2 years. Methods Patients with RRMS starting fingolimod (n=25) or natalizumab (n=30) underwent clinical examination and 3T MRI scans at baseline (month (M) 0), M6, M12 and M24. Seventeen healthy controls were also scanned at M0 and M24. Tensor-based morphometry and SPM12 were used to assess the longitudinal regional GM/WM volume changes. Results At M0, no clinical or GM/WM volume differences were found between treatment groups. At M24, both drugs reduced relapse rate (p<0.001 for both) and stabilised disability. At M6 vs M0, both groups experienced significant atrophy of several areas in the cortex, deep GM nuclei and supratentorial WM. Significant bilateral cerebellar GM and WM atrophy occurred in fingolimod patients only. At M12 vs M6 and M24 vs M12, further supratentorial GM and WM atrophy occurred in both groups. Bilateral GM/WM cerebellar atrophy continued to progress in fingolimod patients only. Compared with natalizumab, fingolimod-treated patients showed a significant cerebellar GM/WM atrophy, mainly at M6 vs M0, but still occurring up to M24. Compared with fingolimod, natalizumab-treated patients had a small number of areas of GM atrophy in temporo-occipital regions at the different time-points. Conclusions Natalizumab and fingolimod are associated with heterogeneous temporal and regional patterns of GM and WM atrophy progression. Compared with natalizumab, fingolimod-treated patients experience accelerated GM and WM atrophy in the cerebellum, while both drugs show minimal regional volumetric differences in supratentorial regions." @default.
• W3008223946 created "2020-03-06" @default.
• W3008223946 creator A5003010065 @default.
• W3008223946 creator A5006120476 @default.
• W3008223946 creator A5033124738 @default.
• W3008223946 creator A5062362541 @default.
• W3008223946 creator A5066806555 @default.
• W3008223946 creator A5084674707 @default.
• W3008223946 creator A5088924447 @default.
• W3008223946 date "2020-02-28" @default.
• W3008223946 modified "2023-10-14" @default.
• W3008223946 title "Two-year regional grey and white matter volume changes with natalizumab and fingolimod" @default.
• W3008223946 cites W1567125068 @default.
• W3008223946 cites W1692776653 @default.
• W3008223946 cites W1826842102 @default.
• W3008223946 cites W1994083593 @default.
• W3008223946 cites W2015334573 @default.
• W3008223946 cites W2019582599 @default.
• W3008223946 cites W2028031986 @default.
• W3008223946 cites W2059982399 @default.
• W3008223946 cites W2076073786 @default.
• W3008223946 cites W2102167158 @default.
• W3008223946 cites W2103758700 @default.
• W3008223946 cites W2104948944 @default.
• W3008223946 cites W2118735809 @default.
• W3008223946 cites W2129718118 @default.
• W3008223946 cites W2151340435 @default.
• W3008223946 cites W2157401887 @default.
• W3008223946 cites W2158048836 @default.
• W3008223946 cites W2162803038 @default.
• W3008223946 cites W2164556363 @default.
• W3008223946 cites W2169212716 @default.
• W3008223946 cites W2191972178 @default.
• W3008223946 cites W2216257364 @default.
• W3008223946 cites W2314548480 @default.
• W3008223946 cites W2328919898 @default.
• W3008223946 cites W2346510270 @default.
• W3008223946 cites W2468275093 @default.
• W3008223946 cites W2524779870 @default.
• W3008223946 cites W2562276035 @default.
• W3008223946 cites W2594840221 @default.
• W3008223946 cites W2766217184 @default.
• W3008223946 cites W2791298772 @default.
• W3008223946 cites W2791439687 @default.
• W3008223946 cites W2811299830 @default.
• W3008223946 cites W2902699417 @default.
• W3008223946 cites W2906066137 @default.
• W3008223946 cites W4211048507 @default.
• W3008223946 doi "https://doi.org/10.1136/jnnp-2019-322439" @default.
• W3008223946 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32111638" @default.
• W3008223946 hasPublicationYear "2020" @default.
• W3008223946 type Work @default.
• W3008223946 sameAs 3008223946 @default.
• W3008223946 citedByCount "8" @default.
• W3008223946 countsByYear W30082239462020 @default.
• W3008223946 countsByYear W30082239462021 @default.
• W3008223946 countsByYear W30082239462022 @default.
• W3008223946 countsByYear W30082239462023 @default.
• W3008223946 crossrefType "journal-article" @default.
• W3008223946 hasAuthorship W3008223946A5003010065 @default.
• W3008223946 hasAuthorship W3008223946A5006120476 @default.
• W3008223946 hasAuthorship W3008223946A5033124738 @default.
• W3008223946 hasAuthorship W3008223946A5062362541 @default.
• W3008223946 hasAuthorship W3008223946A5066806555 @default.
• W3008223946 hasAuthorship W3008223946A5084674707 @default.
• W3008223946 hasAuthorship W3008223946A5088924447 @default.
• W3008223946 hasConcept C126322002 @default.
• W3008223946 hasConcept C126838900 @default.
• W3008223946 hasConcept C142724271 @default.
• W3008223946 hasConcept C143409427 @default.
• W3008223946 hasConcept C203014093 @default.
• W3008223946 hasConcept C2776036978 @default.
• W3008223946 hasConcept C2780640218 @default.
• W3008223946 hasConcept C2781004633 @default.
• W3008223946 hasConcept C2781172350 @default.
• W3008223946 hasConcept C2781192897 @default.
• W3008223946 hasConcept C71924100 @default.
• W3008223946 hasConceptScore W3008223946C126322002 @default.
• W3008223946 hasConceptScore W3008223946C126838900 @default.
• W3008223946 hasConceptScore W3008223946C142724271 @default.
• W3008223946 hasConceptScore W3008223946C143409427 @default.
• W3008223946 hasConceptScore W3008223946C203014093 @default.
• W3008223946 hasConceptScore W3008223946C2776036978 @default.
• W3008223946 hasConceptScore W3008223946C2780640218 @default.
• W3008223946 hasConceptScore W3008223946C2781004633 @default.
• W3008223946 hasConceptScore W3008223946C2781172350 @default.
• W3008223946 hasConceptScore W3008223946C2781192897 @default.
• W3008223946 hasConceptScore W3008223946C71924100 @default.
• W3008223946 hasIssue "5" @default.
• W3008223946 hasLocation W30082239461 @default.
• W3008223946 hasLocation W30082239462 @default.
• W3008223946 hasOpenAccess W3008223946 @default.
• W3008223946 hasPrimaryLocation W30082239461 @default.
• W3008223946 hasRelatedWork W2053484098 @default.
• W3008223946 hasRelatedWork W2082301205 @default.
• W3008223946 hasRelatedWork W2343984847 @default.
• W3008223946 hasRelatedWork W2811112023 @default.
• W3008223946 hasRelatedWork W2977883158 @default.

• next